$102.37
Price
$19.4B
Market Cap
—
P/E Ratio
91.6
Forward P/E
$-5.35
EPS (TTM)
—
Dividend Yield
$1.0B
Cash
$2.8B
Total Debt
190M
Shares Out
$38.81
$102.66
52-Week Range
Institutional Ownership of EXACT SCIENCES CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for EXACT SCIENCES CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for EXACT SCIENCES CORP
6 Months Insider Sentiment
Buy $0
Sell $1.7M
0
Buys
7
Sells
-1.7M
Net
15
Grants
Largest
$780K
Zanotti
$375K
Orville
$200K
Baranick
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 24, 2025 | Brian Baranick | EVP, GM, Precision Oncology | GRANT | 29.4K | — | — |
| Dec 23, 2025 | Aaron Bloomer | EVP, Chief Financial Officer | EXERCISE | 38.7K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | EXERCISE | 4.0K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | EXERCISE | 9.4K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | EXERCISE | 14.8K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | EXERCISE | 16.1K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | EXERCISE | 28.8K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | GRANT | 20.6K | — | — |
| Dec 23, 2025 | Brian Baranick | EVP, GM, Precision Oncology | GRANT | 42.5K | — | — |
| Dec 23, 2025 | Sarah Condella | EVP, Human Resources | GRANT | 34.0K | — | — |
| Dec 23, 2025 | Kevin T Conroy | President and CEO | GRANT | 330.7K | — | — |
| Dec 23, 2025 | Sarah Condella | EVP, Human Resources | EXERCISE | 4.0K | — | — |
| Dec 23, 2025 | Sarah Condella | EVP, Human Resources | EXERCISE | 7.6K | — | — |
| Dec 23, 2025 | Sarah Condella | EVP, Human Resources | EXERCISE | 11.9K | — | — |
| Dec 23, 2025 | Sarah Condella | EVP, Human Resources | EXERCISE | 23.8K | — | — |
| Dec 23, 2025 | Sarah Condella | EVP, Human Resources | GRANT | 8.0K | — | — |
| Dec 23, 2025 | Aaron Bloomer | EVP, Chief Financial Officer | EXERCISE | 24.4K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | EXERCISE | 4.0K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | EXERCISE | 9.4K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | EXERCISE | 14.8K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | EXERCISE | 16.1K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | EXERCISE | 28.8K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | GRANT | 9.4K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | GRANT | 20.6K | — | — |
| Dec 23, 2025 | Jacob A Orville | EVP, GM, Screening | GRANT | 42.5K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | EXERCISE | 1.6K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | EXERCISE | 3.8K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | EXERCISE | 7.1K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | EXERCISE | 7.3K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | EXERCISE | 13.9K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | GRANT | 9.9K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | GRANT | 15.1K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | GRANT | 17.0K | — | — |
| Dec 23, 2025 | James Herriott | SVP, General Counsel & Sec | GRANT | 30.3K | — | — |
| Dec 23, 2025 | Kevin T Conroy | President and CEO | GRANT | 138.3K | — | — |
| Dec 23, 2025 | Kevin T Conroy | President and CEO | GRANT | 244.9K | — | — |
| Nov 19, 2025 | James Herriott | SVP, General Counsel & Sec | SELL | 1.0K | $70.00 | $70K |
| Nov 19, 2025 | Jacob A Orville | EVP, GM, Screening | SELL | 5.0K | $75.00 | $375K |
| Nov 04, 2025 | James Herriott | SVP, General Counsel & Sec | SELL | 1.5K | $70.08 | $105K |
| Nov 04, 2025 | Brian Baranick | EVP, GM, Precision Oncology | SELL | 2.9K | $70.08 | $200K |
| Oct 24, 2025 | Katherine S Zanotti | Director | SELL | 12.0K | $65.00 | $780K |
| Oct 09, 2025 | James Edward Doyle | Director | SELL | 2.0K | $60.00 | $120K |
| Oct 09, 2025 | James Herriott | SVP, General Counsel & Sec | SELL | 1.5K | $60.00 | $90K |